Further, the anti-inflammatory statin atorvastatin (ATV) was identified as a negative modulator of HSPB8, both in in vitro and in vivo atherosclerotic models [125,126], but so far has not been tested in BC. The gene discussed is HSPB8; the disease is breast cancer.